𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Challenges in the development of antimalarial drugs with causal prophylactic activity

✍ Scribed by Jeffrey D. Chulay

Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
433 KB
Volume
92
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of haem in the activity of chlo
The role of haem in the activity of chloroquine and related antimalarial drugs
✍ Timothy J. Egan; Helder M. Marques πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Science 🌐 English βš– 504 KB

Advances made over the last decade indicate that the mechanism of action of important antimalarial agents, such as chloroquine, involves formation of p -p complexes between drugs and ferriprotoporphyrin IX. This process is believed to block the detoxification of host haemoglobin-derived haem in the

Challenges to the development of bryosta
Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase CΞ΄
✍ Kazuhiro Irie; Ryo C. Yanagita; Yu Nakagawa πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

## Abstract Protein kinase C (PKC) isozymes are widely recognized as targets for anticancer therapy, and recent investigations demonstrated that PKC activators are potential therapeutic candidates for Alzheimer's disease and acquired immune deficiency syndrome. However, concerns exist about their t